Prolaris gene expression assay for assessing long-term risk of prostate cancer progression

  • Medtech innovation briefing
  • MIB65
  • Published: 
Download (PDF)

Relevance to NICE guidance programmes

NICE has issued the following guidance:

Prostate cancer: diagnosis and treatment (2014) NICE guideline CG175. Date for review: to be confirmed.